ARCT Q2 2020 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena

ARCTArcturus Therapeutics Holdings Inc.

$210M

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-77.1% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$10M-432.5% margin

Net Income

-$10M-442.0% margin

EPS (Diluted)

$-0.55

QoQ Revenue Growth

-12.2%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$9M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$150M

Total Liabilities

$57M

Stockholders' Equity

$93M

Cash & Equivalents

$136M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$10M	-77.1%
Gross Profit	$2M	$3M	-19.5%
Operating Income	-$10M	-$572,000	-1655.6%
Net Income	-$10M	-$685,000	-1398.2%